A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine

A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine

Objective: This study aimed to investigate the breakthrough infection rate and safety profile of the AstraZeneca vaccine. Methods: The breakthrough COVID-19 infection rate was defined as a positive polymerase chain reaction test 14 days after the vaccine dose. Safety was assessed as local reactions...

Full description

Bibliographic Details
Main Authors: Nawfal R. Hussein, Bizav Naji Rasheed, Ibrahim A. Naqid, Arshed Mustafa Dirbaz, Zana Sidiq M. Saleem, Nashwan Ibrahim, Dildar H. Musa, Sulav Muslih Mohammed
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:Public Health in Practice
Subjects:
SARS-CoV-2
COVID-19
Vaccine side effect
Infection
Efficacy
Online Access:http://www.sciencedirect.com/science/article/pii/S2666535222000799

Internet

http://www.sciencedirect.com/science/article/pii/S2666535222000799

Similar Items